文献速递心力衰竭与心肌病

扩张型心肌病的生物学性别比例:系统综述、荟萃分析与人群研究

Systematic Review, Meta-Analysis, and Population Study to Determine the Biologic Sex Ratio in Dilated Cardiomyopathy.
PubMed 文献 · Circulation · 2025-02-03

遗传变异阳性与基因 elusive 亚组的性别比无显著差异。英国生物银行数据显示,采用性别特异性影像优先或基因优先诊断可部分缩小性别差异,但基因阳性者男性仍占优势,提示存在额外遗传或环境因素驱动性别偏倚的外显率。

要点

  • DCM总体女性比例为0.30,男女比2.38:1。
  • 遗传变异阳性与基因 elusive 亚组的性别比无显著差异。
  • 性别特异性诊断标准可部分缩小性别差异,但基因阳性者男性仍占优势。

核心结论

  • DCM在男性中患病率约为女性的两倍。
  • 采用性别特异性诊断标准可部分缓解性别差异。
  • 基因阳性患者中男性仍占优势,提示额外遗传或环境因素驱动性别偏倚的外显率。

研究设计与样本

  • 排除样本量小(n<100)、儿童或围产期人群的研究。

主要发现

  • 总体DCM队列女性比例为0.30(95%CI 0.28-0.32),男女比2.38:1。
  • 已识别DCM变异患者女性比例为0.31(95%CI 0.26-0.36),男女比2.22:1,与总体无显著差异(P=0.56)。
  • 基因 elusive DCM女性比例为0.30(95%CI 0.24-0.37),男女比2.29:1,与总体无显著差异(P=0.81)。
  • TTN变异女性比例0.28(95%CI 0.22-0.36),男女比2.51:1(P=0.82);LMNA变异女性比例0.35(95%CI 0.27-0.44),男女比1.84:1(P=0.41)。
  • 常染色体显性基因变异所致DCM女性比例0.34(95%CI 0.28-0.40),男女比1.98:1,与全因组无显著差异(P=0.19)。

关键数值与推荐

  • 英国生物银行中,ICD-10编码定义的DCM男女比为4.5:1。
  • 采用性别特异性影像优先诊断方法后男女比变为1.7:1。
  • 采用基因优先诊断方法后男女比变为2.3:1。

临床怎么用

  • 临床诊断DCM时应考虑性别特异性诊断标准,以减少女性漏诊。
  • 基因阳性DCM患者中男性仍占优势,需关注性别偏倚的外显率机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dilated cardiomyopathy (DCM) appears to be diagnosed twice as often in male than in female patients. This could be attributed to underdiagnosis in female patients or sex differences in susceptibility. Up to 30% of cases have an autosomal dominant monogenic cause, where equal sex prevalence would be expected. The aim of this systematic review, meta-analysis, and population study was to assess the sex ratio in patients with DCM, stratified by genetic status, and evaluate whether this is influenced by diagnostic bias. METHODS: A literature search identified DCM patient cohorts with discernible sex ratios. Exclusion criteria were studies with a small (n<100), pediatric, or peripartum population. Meta-analysis and metaregression compared the proportion of female participants for an overall DCM cohort and the following subtypes: all genetic DCM, individual selected DCM genes (TTN and LMNA), and gene-elusive DCM. Population DCM sex ratios generated from diagnostic codes were also compared with those from sex-specific means using the UK Biobank imaging cohort; this established ICD coded, novel imaging-first, and genotype first determined sex ratios. RESULTS: A total of 99 studies, with 37 525 participants, were included. The overall DCM cohort had a 0.30 female proportion (95% CI, 0.28-0.32), corresponding to a male:female ratio (M:F) of 2.38:1. This was similar to patients with an identified DCM variant (0.31 [95% CI, 0.26-0.36]; M:F 2.22:1; P=0.56). There was also no significant difference when compared with patients with gene-elusive DCM (0.30 [95% CI, 0.24-0.37]; M:F 2.29:1; P=0.81). Furthermore, the ratio within autosomal dominant gene variants was not significantly different for TTN (0.28 [95% CI, 0.22-0.36]; M:F 2.51:1; P=0.82) or LMNA (0.35 [95% CI, 0.27-0.44]; M:F 1.84:1; P=0.41). Overall, the sex ratio for DCM in people with disease attributed to autosomal dominant gene variants was similar to the all-cause group (0.34 [95% CI, 0.28-0.40]; M:F 1.98:1; P=0.19). In the UK Biobank (n=47 549), DCM defined by International Classification of Diseases, 10th revision, coding had 4.5:1 M:F. However, implementing sex-specific imaging-first and genotype-first diagnostic approaches changed this to 1.7:1 and 2.3:1, respectively. CONCLUSIONS: This study demonstrates that DCM is twice as prevalent in male patients. This was partially mitigated by implementing sex-specific DCM diagnostic criteria. The persistent male excess in genotype-positive patients with an equally prevalent genetic risk suggests additional genetic or environmental drivers for sex-biased penetrance. REGISTRATION: URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42023451944.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Bergan N, Prachee I, Curran L, et al. Systematic Review, Meta-Analysis, and Population Study to Determine the Biologic Sex Ratio in Dilated Cardiomyopathy. Circulation. 2025. PMID: 39895490. doi:10.1161/CIRCULATIONAHA.124.070872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。